Hefsa Al Shamsi
Doctor
Abu Dhabi
United Arab Emirates
Biography
Dr. Hefsa has completed her fellowship of nephrology in Sheikh khalifah medical center Abu Dhabi, United Arab Emirates in 2018 at the age of 35. She is working as a nephrologist in SKMC and activly invoved in the care of dialysis patients and kidney transpant patients. She is also working in completing her Master degree in renal transplant from liverpool university online course.
Research Interest
Glomerulonephritis (GN) is a rising paramount renal disease that varies in etiology from inherited or acquired factors. Its severity can range from asymptomatic depictions to end stage kidney disease (ESKD). The aim of this study was to study patterns of biopsy-proven glomerulonephritis based on data from a multicenters in Abu Dhabi. Included kidney biopsy were from all patients above the age of 18 years, over a six-year period from 2010 till 2015, who had diagnosis of glomerular disease other than diabetes mellitus. The number of reviewed biopsies was 416. The most common type of glomerulonephritis among the study sample were the IgA GN (22.8) followed by the FSGS (20.4%) followed by the SLE (19.7%). The least common types were Pauci Immune (1.7). There was female preponderance in lupus nephritis and pauci immune GN. The nationality comparison did not reveal a predominate GN among Emirati nationals. The age relationship to GN types showed that the majority (82.9%) of SLE patients, MCD (74.55 %) and non- categorized (71.4%) patients are young between the age of 18 to 39 years. On the other hand, 57.1%, 25% and 16.7% of patients with Pauci immune, other GN types and MPGN respectively are 60 years and older. This study shows the histopathological variety of glomerular disease in Abu Dhabi. It could be a driving point to help understand GN better in the region.